Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma

THURSDAY, Aug. 19, 2021 -- For patients with clear-cell renal cell carcinoma at high risk for recurrence after nephrectomy, adjuvant therapy with pembrolizumab improves disease-free survival, according to a study published in the Aug. 19 issue of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news